Selected article for: "diphtheria toxoid vaccine and toxoid vaccine"

Author: Kwon, Hyo Jin; Yum, Sook Kyung; Choi, Ui Yoon; Lee, Soo Young; Kim, Jong Hyun; Kang, Jin Han
Title: Infant Pertussis and Household Transmission in Korea
  • Document date: 2012_12_7
  • ID: zz1zarbk_2
    Snippet: The epidemiological characteristics of pertussis can vary depending on the definition of case, diagnostic method of confirmed case, national reporting system, network organization for epidemiological investigation, and the local vaccination schedule. National immunization program (NIP) of Korea consists of three primary series of diphtheria-tetanus-acellular pertussis vaccine (DTaP) at 2, 4, and 6 months, followed by a first booster at 15-18 mont.....
    Document: The epidemiological characteristics of pertussis can vary depending on the definition of case, diagnostic method of confirmed case, national reporting system, network organization for epidemiological investigation, and the local vaccination schedule. National immunization program (NIP) of Korea consists of three primary series of diphtheria-tetanus-acellular pertussis vaccine (DTaP) at 2, 4, and 6 months, followed by a first booster at 15-18 months and a second booster between 4 and 6 yr of age. Recently, a tetanus toxoid, reduced diphtheria and acellular pertussis (Tdap) booster vaccine in adolescents aged 11-12 yr is added to Korean NIP in 2012. The vaccination rate of primary DTaP continues to be approximately 94% (12, 13) , and there is a mandatory notification system in Korea. An annual average of about 11.5 cases of pertussis has been reported to the Korea Center for Disease Control and Prevention (KCDC), however, the reported cases of pertussis have increased since the 2000s. In addition, the KCDC reported that the incidence of pertussis was markedly increased (more than about 5.5 times) in 2009, compared to the previous (14) . Also, the incidence of pertussis in 2011 was more than two times compared with the incidence in 2009 (15) . We may predict the substantial outbreak in the future in our country.

    Search related documents:
    Co phrase search for related documents
    • acellular pertussis vaccine and case definition: 1
    • acellular pertussis vaccine and diphtheria tetanus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acellular pertussis vaccine and diphtheria tetanus DTaP acellular pertussis vaccine: 1, 2, 3
    • acellular pertussis vaccine and DTaP acellular pertussis vaccine: 1, 2, 3, 4
    • acellular pertussis vaccine and pertussis case: 1
    • acellular pertussis vaccine and pertussis incidence: 1, 2, 3, 4, 5
    • acellular pertussis vaccine and pertussis Tdap booster vaccine: 1
    • acellular pertussis vaccine and pertussis vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • acellular pertussis vaccine and primary series: 1
    • acellular pertussis vaccine and report case: 1
    • acellular pertussis vaccine and Tdap booster vaccine: 1
    • acellular pertussis vaccine and tetanus toxoid: 1, 2, 3, 4
    • acellular pertussis vaccine and vaccination schedule: 1, 2, 3
    • age adolescent and booster vaccine: 1
    • age adolescent and diphtheria tetanus: 1
    • age adolescent and report case: 1, 2
    • annual average and case definition: 1, 2
    • annual average and epidemiological characteristic: 1
    • annual average and immunization program: 1